1. Home
  2. KLTO vs VERB Comparison

KLTO vs VERB Comparison

Compare KLTO & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • VERB
  • Stock Information
  • Founded
  • KLTO 2019
  • VERB 2014
  • Country
  • KLTO United States
  • VERB United States
  • Employees
  • KLTO N/A
  • VERB N/A
  • Industry
  • KLTO
  • VERB Other Consumer Services
  • Sector
  • KLTO
  • VERB Consumer Discretionary
  • Exchange
  • KLTO NYSE
  • VERB Nasdaq
  • Market Cap
  • KLTO 5.9M
  • VERB 5.8M
  • IPO Year
  • KLTO N/A
  • VERB N/A
  • Fundamental
  • Price
  • KLTO $0.71
  • VERB $7.32
  • Analyst Decision
  • KLTO
  • VERB Strong Buy
  • Analyst Count
  • KLTO 0
  • VERB 1
  • Target Price
  • KLTO N/A
  • VERB $62.00
  • AVG Volume (30 Days)
  • KLTO 84.5M
  • VERB 42.6K
  • Earning Date
  • KLTO 08-15-2025
  • VERB 08-13-2025
  • Dividend Yield
  • KLTO N/A
  • VERB N/A
  • EPS Growth
  • KLTO N/A
  • VERB N/A
  • EPS
  • KLTO N/A
  • VERB N/A
  • Revenue
  • KLTO N/A
  • VERB $2,193,000.00
  • Revenue This Year
  • KLTO N/A
  • VERB $526.82
  • Revenue Next Year
  • KLTO N/A
  • VERB $45.45
  • P/E Ratio
  • KLTO N/A
  • VERB N/A
  • Revenue Growth
  • KLTO N/A
  • VERB 3125.00
  • 52 Week Low
  • KLTO $0.11
  • VERB $3.81
  • 52 Week High
  • KLTO $3.91
  • VERB $27.14
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • VERB 52.71
  • Support Level
  • KLTO N/A
  • VERB $6.38
  • Resistance Level
  • KLTO N/A
  • VERB $7.15
  • Average True Range (ATR)
  • KLTO 0.00
  • VERB 0.68
  • MACD
  • KLTO 0.00
  • VERB -0.17
  • Stochastic Oscillator
  • KLTO 0.00
  • VERB 25.90

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.

Share on Social Networks: